Multipotent action of Rhizophora mucronata (red mangrove) as neuroprotective drug against Alzheimer’s disease – Evidence from preclinical studies by N, Suganthy










Abstract

	The thesis entitled “Multipotent action of Rhizophora mucronata (Red mangrove) as neuroprotective drug against Alzheimer’s disease – Evidence from preclinical studies” deals with the study of neuroprotective effect of Rhizophora mucronata against Alzheimer’s disease (AD) through its multipotent action in  in vitro (PC12 cells) and in vivo model systems (mice). The thesis is typically divided in six chapters.

	Chapter I: In vitro screening of Rhizophora mucronata for its multipotent neuroprotective effect - Antioxidant, Cholinesterase inhibitory, Metal chelating and Anti-amyloidogenic property.
	Chapter II: Nutritional evaluation of Rhizophora mucronata leaves.
	Chapter III: Safety and Toxicity evaluation of Rhizophora mucronata methanolic leaf extract: in vitro and in vivo study.
	Chapter IV: Neuroprotective effects of Rhizophora mucronata against beta-amyloid-induced cell death in PC12 cells via its antioxidant mechanism.
	Chapter V: Anti-amnestic and neuroprotective effect of methanolic leaf extract of Rhizophora mucronata against A (25-35) induced toxicity in Swiss Albino mice.
	Chapter VI: Bioassay-directed isolation of active compounds with neuroprotective effect from Rhizophora mucronata leaf extract.
	
	Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized clinically by insidious onset of memory and cognitive impairment, emergence of psychiatric symptoms and behavioral disorder, and impairment of activities of daily life. AD one of the fourth leading causative of death, affects about 26.6 million people worldwide, which might quadruple to 106.8 million by 2050 if no therapy intervenes. Multiple causative factors such as - amyloid (A) aggregation,-protein aggregation, oxidative stress and cholinergic hypothesis plays major role in the pathogenesis of AD, among which, Aβ peptide plays a pivotal role. Currently AChE inhibitors such as tacrine, donepezil, rivastigmine and galanthamine are used for the treatment of mild to moderate AD as approved by Food and Drug Administration. However these drugs possess severe gastrointestinal side effects and are effective only for mild to moderate forms of AD. Diverse pathogenic factors and safety limitation of currently used synthetic drugs necessitates exploration of multipotent drug from natural source to hit more than one target implicated in AD. 
	Rhizophora mucronata commonly termed as Asiatic mangrove have been valued for its timber and ethanomedicinal properties. In traditional medicine, leaves of R. mucronata have been used for the treatment of elephantitis, hematoma, hepatitis, ulcers, inflammation and febrifuge.  In addition the leaves have been used as alternative source of tea and as animal feed. The leaves have also been reported for its pharmacological properties such as anti-diabetic, anti-inflammatory, anti-viral activity and anti-diarrheal effect. Despite of its wide pharmacological properties, the application of R. mucronata in the treatment of neurological disorder is still at its infancy. Mangroves in general are halophyte which possess rich source of antioxidant system to overcome the oxidative stress induced by salt stress environment. Since A peptides leads to neuronal death and cognitive deficits through oxidative stress, it was attempted to screen the mangrove R. mucronata, which has rich antioxidant and anti-inflammatory property, for its neuroprotective effect. We have attempted to evaluate the neuroprotective activity of Rhizophora mucronata against AD through its multipotent action.
	The chapter I “In vitro screening of Rhizophora mucronata for its multipotent neuroprotective effect - Antioxidant, Cholinesterase inhibitory, Metal chelating and Anti-amyloidogenic property” deals with screening different mangroves for its potent antioxidant, cholinesterase inhibitory activity, metal chelating and antiaggregation property. Nine mangroves (Avicennia marina, Rhizophora mucronata, Rhizophora lamarkii Rhizophora apiculata, Rhizophora annamalayana, Ceriops decandra, Sweda maritima, Pruscaria celligrica and Lumnitzera racemosa) collected from Pichavaram, Vellar estuary, Tamil Nadu, India were used for the present study. Screening for cholinesterase and antioxidant activity of mangroves showed that of the nine mangroves screened, leaf extract of R. mucronata exhibited potent antioxidant and dual cholinesterase inhibitory activity. Further, successive solvent extracts from the leaves of R. mucronata were assessed for its multipotent neuroprotective effect (antioxidant, cholinesterase inhibitory and metal chelating activity).  Of the various solvents, methanolic leaf extract of R. mucronata (MERM) displayed remarked inhibition against both AChE and BuChE exhibiting dual cholinergic effect.  In vitro antioxidant assays showed that MERM showed excellent reducing power and free radical scavenging activity. Assessment of antiamyloidogenic property illustrates that MERM inhibits Aβ fibrillogenesis and also destabilizes the preformed fibrils. To the best of our knowledge, this is the ﬁrst study describing anticholinesterase and antioxidant activity using ferrous ion-chelating, nitric oxide, hydroxyl radical scavenging and ferric-reducing antioxidant power (FRAP) assays of the afore-mentioned mangrove species. Since MERM acts as multifunctional agent exhibiting cholinesterase inhibition, antioxidant, metal chelating property, antiaggregation and deaggregation of Aβ fibrils, it can act as a potent drug to combat the multiple targets of AD. The multipotent activity of MERM could be attributed to the presence of high amount of total phenol and ﬂavonoid contents.
 	The chapter 2 “Nutritional evaluation of Rhizophora mucronata leaves” deals with nutritional analysis of R. mucronata, its proximate composition, amino acid profiles and physicochemical properties in comparison with green leafy vegetables consumed in India.  Proximate composition analysis showed that R. mucronata act as a good source of dietary fiber, lipid and protein content suitable for human consumption. The study also detected the presence of seventeen amino acids with higher essential amino acid content which were comparable to FAO/WHO requirement. Presence of higher levels of Linoleic acid, alpha linolenic acid and low levels of saturated fatty acid signifies the leaves as nutritionally balanced diet. Leaves also act as rich source of ascorbic acid, thiamine, riboflavin, tocopherol, Na+, Fe2+ and Ca2+ which could help in overcoming micronutrient malnutrition at a negligible cost. Physicochemical properties of leaves had a high positive correlation with their total amount of fiber and protein content. Overall, the leaves of R. mucronata could be used as a potential health food in human diets and may be of use to the food industry as a source of ingredients with high nutritional value.
	Safe use as plant-based medicine, beside historical and experienced applications on humans and animals, requires toxicity evaluation of these medicinal herbs.  Hence Chapter III “Safety and Toxicity evaluation of Rhizophora mucronata methanolic leaf extract: in vitro and in vivo study” deals with assessment of toxic effect of MERM under in vitro (mutagenic, genotoxic, cytotoxic) and in vivo conditions (Acute and Sub-acute toxicity). Results of Salmonella/microsome assay shows that MERM produced neither frame shift mutation in TA98 and TA1538 nor base pair substitution in TA100 and TA1535.  Lack of mutagenic effect of MERM at concentrations up to 4000 µg/plate in all the tester strains provides reassurance on the safety of the extracts widely used in traditional medicine. In addition MERM exhibited antimutagenic effect against direct acting mutagens (Sodium azide) in both TA98 and TA 100 tester strains. Investigation of cytotoxic effect by trypan blue exclusion assay and MTT assay showed that MERM had no cytotoxic effect on PBMC up to 24 hrs. Evaluation of genotoxicity (comet assay) revealed that MERM (2000 µg/ml) showed no significant difference in comet tail moment and tail scores which concludes that MERM has no genotoxic effect. In vitro hemolytic activity showed that MERM showed no significant (p  0.05) hemolytic effect even at the maximum dose (2000 µg/ml), which indicates that leaf extract preserves the integrity of cell membranes. In acute toxicity studies oral administration of MERM (250-2000 mg/kg) in Wistar rats produced neither mortality nor any noticeable changes in behavior. Hematological and biochemical parameters showed no difference, except for a significant increase in ALT and AST at the highest dose. Histopathological findings revealed hepatotoxicity and neurotoxicity at highest dose of extract. In sub-acute toxicity studies administration of MERM (1000 mg/kg) for 28 consecutive days neither altered the body weight gain nor behavioral parameters. No significant change was observed in the hematological and biochemical parameters analyzed. Histopathological examination showed normal architecture suggesting no morphological disturbances. Collectively, these data demonstrate that consumption of MERM for various medicinal purposes is safe.
	Chapter IV “Neuroprotective effect of Rhizophora mucronata against beta-amyloid-induced cell death in PC12 cells via its antioxidant mechanism” deals with various mechanism by which MERM protects against A induced toxicity in PC12 cells. PC12 cells used for the current study are widely used for in vitro research on AD as these cells contain many membrane-bound and cytosolic molecules associated with neurons, and are electrically excitable and neurosecretory. In addition PC12 cells were found to be more sensitive to Aβ insult hence it has been used extensively to study Aβ induced cellular toxicity. A (25-35) treatment in PC12 cells (2  105 cells/ml) for 24 hrs at 20 M concentration reduced cell viability, altered the morphology,  induced ROS/RNS production, decreased mitochondrial membrane potential, deregulated intracellular calcium levels and caused macromolecular damage. MERM pretreatment prior to A (25-35) exposure significantly elevated cell viability, reduced A (25-35) induced apoptosis, decreased ROS/RNS production, stabilized mitochondrial membrane potential, attenuated caspase 3 activation, maintained intracellular calcium homeostasis and  inhibited protein and lipid oxidation.  MERM also restores the antioxidant status of the cell by maintaining the antioxidant enzymes (SOD, CAT). MERM maintains the intracellular Glutathione level by regulating glutathione metabolizing enzyme (GR, GPx and GST). MERM also inhibits both acetyl and butyryl cholinesterase activity. Our findings suggest that MERM, a multiple-target drug holds potential for neuroprotection and therefore, may be promising for the treatment of AD. This effect of MERM could be due to the active compounds present in it, which may increase the capacity of endogenous antioxidant defense and may modulate the cellular redox state.
	Animal models play a critical role in understanding the pathology and screening of therapeutics for AD.  Although no available model can meet all the full pathologic spectrum of AD disease, the injection of Aβ into the brain was shown to impair learning and memory, and elicit a degree of AD type neurodegeneration. Chapter V “Anti-amnesic and neuroprotective effect of methanolic leaf extract of Rhizophora mucronata against A (25-35) induced toxicity in Swiss Albino mice” deals with possible mechanism by which MERM combats A (25-35) induced toxicity under in vivo condition. Mice were fed orally with 200 and 400 mg/kg bw for 21 days followed by single intracerebroventricular (i.c.v.) injection of A (25-35) (10 g/mouse). Behavioral changes in the mice were evaluated using water maze, Y-maze and passive avoidance tests. The consumption of MERM significantly ameliorated the cognitive deficits caused by i.c.v. injection of A (25-35) by restoring spatial memory, improving short term memory (STM) and long term memory (LTM). MERM enhances cholinergic effect by inhibiting both AChE and BuChE, attenuating lipid peroxidation and protein oxidation, reducing ROS and RNS level by activating antioxidative defense system (SOD, CAT) and  restoring glutathione metabolizing enzyme systems (GPX, GR and GST). MERM inhibits BACE1 activity thereby reducing the formation of neuronal tangles as observed in histopathological analysis. MERM inhibits neuronal apoptosis by suppressing both caspase-3 and MAO-B activity. Taken together, the results conclude that exogenous administration of MERM provides neuroprotective effect against toxic effect of Aβ peptide in regions related to cognitive functions providing new insight for future therapeutic approaches of AD.
	Chapter VI “Bioassay-directed isolation of active compounds with neuroprotective effect from Rhizophora mucronata leaf extract” deals with isolation and identification of bioactive compound responsible for the neuroprotective effect. MERM was fractionated using silica column chromatography (60-120 mesh) with solvents from nonpolar to polar (benzene to water) in various ratios and the eluted fractions were freeze dried. The fractions were subjected to bioactive guided fractionation using in vitro antioxidant and cholinesterase inhibitory assays. Among the various fractions Ethyl acetate: Methanol (1:1) fraction (Fr 14) showed the highest antioxidant and cholinesterase inhibitory activity. TLC analysis of the active fraction using Vanillin-Sulphuric acid showed the presence of four pink and two yellow colored bands. Preliminary phytochemical analysis showed the presence of flavonoids, terpenoids and glycosides. TLC chromatogram sprayed with p-anisaldehyde sulphuric acid and 1% Alcoholic aluminium chloride showed purple colored bands in visible light and fluorescent yellow colored bands under UV 366 nm, confirming the presence of terpenoids and flavonoids. The active fraction 14 was further fractionated by HPLC using methanol : water by binary gradient method. Among the eight fractions eluted, fraction 3 showed the highest AChE and BuChE inhibitory activity with IC 50 value of 32.25  0.001 and 40  0.002 g/ml respectively. Enzyme kinetic studies showed that the active fraction exhibited competitive and mixed type of inhibition against AChE and BuChE. 
TLC chromatogram analysis of active fraction sprayed with alcoholic aluminum chloride showed single fluorescence band with Rf value of 0.6 which confirmed the presence of flavonoids. Structural elucidation using FTIR, UV scan, C13 and H1 NMR spectrum illustrated that the content present  in bioactive fraction 3 was (+) - catechin (C15H14O6) a flavones-3-ol with molecular weight of 290.27. The identity was further confirmed by comparison with authentic sample (Sigma Aldrich, Bangalore) using LC-MS. 
	To conclude, the present work represents a comprehensive study of multipotent neuroprotective role of Rhizophora mucronata and its constituent (+)-Catechin against AD. Overall results of in vitro and in vivo studies validated the hypothesis that exogenous administration of MERM exerts neuroprotective actions against toxic effects of Aβ peptides in regions related to cognitive functions providing new insight for future therapeutic approaches of AD. Results of safety evaluation illustrates that MERM used for the present study is devoid of toxic effect both under in vitro and in vivo conditions which assures the safe usage of traditional drug. Despite of its neuroprotective effect, the rich nutritive value indicates that leaves can be used as nutraceuticals.  Moreover this is the first report regarding the neuroprotective role of mangrove, hence the present work offers new insight for exploration of drugs from marine natural products for the treatment of AD. 
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